We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention (SAVI-PCI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01522417
Recruitment Status : Recruiting
First Posted : January 31, 2012
Last Update Posted : March 12, 2018
SCRI Development Innovations, LLC
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 2019
  Estimated Study Completion Date : July 2019